Charles E. Alpers

University of Washington — United States

Medicine · Health Sciences

107h-index44.0kcitations552works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(215), Chronic Kidney Disease and Diabetes(102), Amyloidosis: Diagnosis, Treatment, Outcomes(46), Systemic Lupus Erythematosus Research(45), Complement system in diseases(38)

Publications532 total

Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project
Kidney Medicine·2025Open Access
Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human Kidney
2025· 1 citedOpen Access
AJKD Atlas of Renal Pathology: Crystalglobulin-Induced Nephropathy
American Journal of Kidney Diseases·2025
Hemodynamics are associated with subsequent lumen remodeling and clinical maturation of hemodialysis arteriovenous fistula
Scientific Reports·2025· 5 citedOpen Access
Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells
Science Translational Medicine·2024· 22 citedOpen Access
nPOD-Kidney: A Heterogenous Donor Cohort for the Investigation of Diabetic Kidney Disease Pathogenesis and Progression
Kidney360·2024Open Access
Autophagy-Related Gene Expression in Diabetes and CKD
Journal of the American Society of Nephrology·2024
A <i>MEF2C</i> transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease
2024· 2 citedOpen Access
Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes
JCI Insight·2024· 6 citedOpen Access
Seeing through the density of dense deposit disease
Kidney International·2024Open Access
Heparin decreases blood pressure and response to exogenous endothelin but does not protect against chronic experimental cyclosporine nephropathy
UNC Libraries·2024Open Access
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
Kidney International Reports·2024· 3 citedOpen Access
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
Clinical Journal of the American Society of Nephrology·2024· 26 citedOpen Access
AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis
American Journal of Kidney Diseases·2023· 9 citedOpen Access
Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can’t Have One Without the Other
The Journal of Rheumatology·2023· 1 citedOpen Access
Single cell spatial transcriptomic profiling of childhood-onset lupus nephritis reveals complex interactions between kidney stroma and infiltrating immune cells
2023· 9 citedOpen Access
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet·2023· 226 citedOpen Access
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
New England Journal of Medicine·2023· 96 cited
Biopsy Features of Initial KPMP Participants with CKD and Diabetes or Hypertension
Journal of the American Society of Nephrology·2023
Spatially Localized Mesangial Cell Communication in Diabetic Kidney Disease
Journal of the American Society of Nephrology·2023
page 1 of 27Next →

Frequent Co-authors

Agnes B. Fogo(12), Vivette D. D’Agati(10), Mark Haas(10), Jonathan Barratt(10), Richard J. Johnson(9), William G. Couser(9), Jürgen Floege(9), J. Charles Jennette(8), S. A. Roberts(8), Franco Ferrario(7), Rosanna Coppo(7), Kelly L. Hudkins(7), Jan J. Weening(6), John Feehally(6), Fernando C. Fervenza(6), Katherine Gordon(6), Gerald B. Appel(5), Daniel C. Cattran(5), Kensuke Joh(5), Zhihong Liu(5)